Registration for Remote Access IOP Program Now Open
FRIDAY NIGHT GUEST LECTURE SERIES 2023-24
This event highlights the subjective effects of certain psychedelics, including their potential benefits and risks, and describes the clinical protocol of the FDA-approved research trial of MDMA-assisted therapy for PTSD along with outcomes. Aspects of the clinical interface of psychedelic-assisted therapy and psychoanalytically-oriented treatment, including reconceptualization of the therapeutic alliance and frame, transference and countertransference issues, referral considerations, and contraindications to PAT will be discussed.